RHC 3659: a new orally active angiotensin converting enzyme inhibitor in normal volunteers.
Open Access
- 1 December 1981
- journal article
- Published by Wiley
- Vol. 12 (6) , 893-899
- https://doi.org/10.1111/j.1365-2125.1981.tb01327.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A new class of angiotensin-converting enzyme inhibitorsNature, 1980
- Active Transport of Sodium and Potassium IonsNew England Journal of Medicine, 1980
- The Measurement of Angiotensin-Converting Enzyme in Subjects Receiving CaptoprilNew England Journal of Medicine, 1980
- Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting EnzymeNew England Journal of Medicine, 1979
- IMPROVEMENT OF CHRONIC CONGESTIVE HEART-FAILURE BY ORAL CAPTOPRILThe Lancet, 1979
- Converting enzyme inhibition with an orally active compound in hypertensive man.Hypertension, 1978
- Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patientsProgress in Cardiovascular Diseases, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977
- Estimation of Angiotensin II Concentration in Human Plasma by Radioimmunoassay. Some Applications to Physiological and Clinical StatesEuropean Journal of Clinical Investigation, 1971